Cite
Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26
MLA
Aktas, Y., et al. “Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26.” Bioconjugate Chemistry, vol. 16, no. 6, Nov. 2005, pp. 1503–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs8144891&authtype=sso&custid=ns315887.
APA
Aktas, Y., Yemisci, M., Andrieux, K., Gursoy, R. N., Alonso, M. J., Fernandez-Megia, E., Novoa-Carballal, R., Quinoa, E., Riguera, R., Sargon, M. F., Celik, H. H., Demir, A. S., Hincal, A. A., Dalkara, T., Capan, Y., & Couvreur, P. (2005). Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26. Bioconjugate Chemistry, 16(6), 1503–1511.
Chicago
Aktas, Y., M. Yemisci, K. Andrieux, R. N. Gursoy, M. J. Alonso, E. Fernandez-Megia, R. Novoa-Carballal, et al. 2005. “Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26.” Bioconjugate Chemistry 16 (6): 1503–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs8144891&authtype=sso&custid=ns315887.